A Novel Deep Learning Based Multi-class Classification Method for Alzheimer’s Disease Detection Using Brain MRI Data

Author(s):  
Jyoti Islam ◽  
Yanqing Zhang
2021 ◽  
Vol 19 (11) ◽  
pp. 126-140
Author(s):  
Zahraa S. Aaraji ◽  
Hawraa H. Abbas

Neuroimaging data analysis has attracted a great deal of attention with respect to the accurate diagnosis of Alzheimer’s disease (AD). Magnetic Resonance Imaging (MRI) scanners have thus been commonly used to study AD-related brain structural variations, providing images that demonstrate both morphometric and anatomical changes in the human brain. Deep learning algorithms have already been effectively exploited in other medical image processing applications to identify features and recognise patterns for many diseases that affect the brain and other organs; this paper extends on this to describe a novel computer aided software pipeline for the classification and early diagnosis of AD. The proposed method uses two types of three-dimensional Convolutional Neural Networks (3D CNN) to facilitate brain MRI data analysis and automatic feature extraction and classification, so that pre-processing and post-processing are utilised to normalise the MRI data and facilitate pattern recognition. The experimental results show that the proposed approach achieves 97.5%, 82.5%, and 83.75% accuracy in terms of binary classification AD vs. cognitively normal (CN), CN vs. mild cognitive impairment (MCI) and MCI vs. AD, respectively, as well as 85% accuracy for multi class-classification, based on publicly available data sets from the Alzheimer’s disease Neuroimaging Initiative (ADNI).


2020 ◽  
Vol 13 (4) ◽  
pp. 495-505 ◽  
Author(s):  
Sanjiban Sekhar Roy ◽  
Raghav Sikaria ◽  
Aarti Susan

2020 ◽  
Author(s):  
Bin Lu ◽  
Hui-Xian Li ◽  
Zhi-Kai Chang ◽  
Le Li ◽  
Ning-Xuan Chen ◽  
...  

AbstractBeyond detecting brain damage or tumors, little success has been attained on identifying individual differences and brain disorders with magnetic resonance imaging (MRI). Here, we sought to build industrial-grade brain imaging-based classifiers to infer two types of such inter-individual differences: sex and Alzheimer’s disease (AD), using deep learning/transfer learning on big data. We pooled brain structural data from 217 sites/scanners to constitute the largest brain MRI sample to date (85,721 samples from 50,876 participants), and applied a state-of-the-art deep convolutional neural network, Inception-ResNet-V2, to build a sex classifier with high generalizability. In cross-dataset-validation, the sex classification model was able to classify the sex of any participant with brain structural imaging data from any scanner with 94.9% accuracy. We then applied transfer learning based on this model to objectively diagnose AD, achieving 88.4% accuracy in cross-site-validation on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset and 91.2% / 86.1% accuracy for a direct test on two unseen independent datasets (AIBL / OASIS). Directly testing this AD classifier on brain images of unseen mild cognitive impairment (MCI) patients, the model correctly predicted 63.2% who eventually converted into AD, versus predicting 22.1% as AD who did not convert into AD during follow-up. Predicted scores of the AD classifier correlated significantly with illness severity. By contrast, the transfer learning framework was unable to achieve practical accuracy for psychiatric disorders. To improve interpretability of the deep learning models, occlusion tests revealed that hypothalamus, superior vermis, thalamus, amygdala and limbic system areas were critical for predicting sex; hippocampus, parahippocampal gyrus, putamen and insula played key roles in predicting AD. Our trained model, code, preprocessed data and an online prediction website have been openly-shared to advance the clinical utility of brain imaging.


2021 ◽  
Vol 56 (5) ◽  
pp. 241-252
Author(s):  
Shereen A. El-Aal ◽  
Neveen I. Ghali

Alzheimer's disease (AD) is an advanced and incurable neurodegenerative disease that causes progressive impairment of memory and cognitive functions due to the deterioration of brain cells. Early diagnosis is substantial to avoid permanent memory loss and develop treatments that will be subtracted in the future. Deep learning (DL) is a vital technique for medical imaging systems for AD diagnostics. The problem is multi-class classification seeking high accuracy. DL models have shown strong performance accuracy for multi-class prediction. In this paper, a proposed DL architecture is created to classify magnetic resonance imaging (MRI) to predict different stages of AD-based pre-trained Convolutional Neural Network (CNN) models and optimization algorithms. The proposed model architecture attempts to find the optimal subset of features to improve classification accuracy and reduce classification time. The pre-trained DL models, ResNet-101 and DenseNet-201, are utilized to extract features based on the last layer, and the Rival Genetic algorithm (RGA) and Pbest-Guide Binary Particle Swarm Optimization (PBPSO) are applied to select the optimal features. Then, the DL features and selected features are passed separately through created classifier for classification. The results are compared and analyzed by accuracy, performance metrics, and execution time. Experimental results showed that the most efficient accuracies were obtained by PBPSO selected features which reached 87.3% and 94.8% accuracy with less time of 46.7 sec, 32.7 sec for features based ResNet-101 and DenseNet-201, receptively.


Sign in / Sign up

Export Citation Format

Share Document